MedWatch·Industry news·Business & finance·6d agoDemant CEO steps up efforts despite tough competition ahead: “We’re not done yet”Intensifying competition among major hearing-aid manufacturers could accelerate product innovation and affect pricing and supply options available to clinics.
MedWatch·Financial report·Business & finance·6d agoDemant CEO on upward revision: “There is strong momentum in the business”Demant's upward financial revision signals continued market expansion in the hearing industry, which may influence competitive dynamics, pricing, and product investment across the sector.＋Save
Audiology Worldnews·Industry news·Business & finance·6w agoDemant appoints new lead of Hearing Aids so Nielsen can sharpen CEO focusLeadership restructuring at a top-three global hearing aid manufacturer can signal shifts in strategic direction — such as R&D priorities, market positioning, or partnership focus — that may eventually affect product availability and clinical options.＋Save
